<HashMap><database>biostudies-other</database><scores/><additional><submitter>Kishore S</submitter><funding>NCRR NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>1153-64</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2838533</full_dataset_link><abstract>The loss of HBII-52 and related C/D box small nucleolar RNA (snoRNA) expression units have been implicated as a cause for the Prader-Willi syndrome (PWS). We recently found that the C/D box snoRNA HBII-52 changes the alternative splicing of the serotonin receptor 2C pre-mRNA, which is different from the traditional C/D box snoRNA function in non-mRNA methylation. Using bioinformatic predictions and experimental verification, we identified five pre-mRNAs (DPM2, TAF1, RALGPS1, PBRM1 and CRHR1) containing alternative exons that are regulated by MBII-52, the mouse homolog of HBII-52. Analysis of a single member of the MBII-52 cluster of snoRNAs by RNase protection and northern blot analysis shows that the MBII-52 expressing unit generates shorter RNAs that originate from the full-length MBII-52 snoRNA through additional processing steps. These novel RNAs associate with hnRNPs and not with proteins associated with canonical C/D box snoRNAs. Our data indicate that not a traditional C/D box snoRNA MBII-52, but a processed version lacking the snoRNA stem is the predominant MBII-52 RNA missing in PWS. This processed snoRNA functions in alternative splice-site selection. Its substitution could be a therapeutic principle for PWS.</abstract><repository>biostudies-other</repository><data_source>Europe PMC</data_source><omics_type>Unknown</omics_type><volume>19(7)</volume><journal>Human molecular genetics</journal><pmcid>PMC2838533</pmcid><funding_grant_id>R01 GM083187-01A2</funding_grant_id><funding_grant_id>GM083187</funding_grant_id><funding_grant_id>R01 GM083187</funding_grant_id><funding_grant_id>P20 RR020171</funding_grant_id><pubmed_authors>Stamm S</pubmed_authors><pubmed_authors>Stefan M</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Balwierz PJ</pubmed_authors><pubmed_authors>Khanna A</pubmed_authors><pubmed_authors>Nicholls RD</pubmed_authors><pubmed_authors>Hui J</pubmed_authors><pubmed_authors>Kishore S</pubmed_authors><pubmed_authors>Beach C</pubmed_authors><pubmed_authors>Zavolan M</pubmed_authors></additional><is_claimable>false</is_claimable><name>The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing.</name><description>The loss of HBII-52 and related C/D box small nucleolar RNA (snoRNA) expression units have been implicated as a cause for the Prader-Willi syndrome (PWS). We recently found that the C/D box snoRNA HBII-52 changes the alternative splicing of the serotonin receptor 2C pre-mRNA, which is different from the traditional C/D box snoRNA function in non-mRNA methylation. Using bioinformatic predictions and experimental verification, we identified five pre-mRNAs (DPM2, TAF1, RALGPS1, PBRM1 and CRHR1) containing alternative exons that are regulated by MBII-52, the mouse homolog of HBII-52. Analysis of a single member of the MBII-52 cluster of snoRNAs by RNase protection and northern blot analysis shows that the MBII-52 expressing unit generates shorter RNAs that originate from the full-length MBII-52 snoRNA through additional processing steps. These novel RNAs associate with hnRNPs and not with proteins associated with canonical C/D box snoRNAs. Our data indicate that not a traditional C/D box snoRNA MBII-52, but a processed version lacking the snoRNA stem is the predominant MBII-52 RNA missing in PWS. This processed snoRNA functions in alternative splice-site selection. Its substitution could be a therapeutic principle for PWS.</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Apr</publication><modification>2019-03-27T00:29:23Z</modification><creation>2019-03-27T00:29:23Z</creation></dates><accession>S-EPMC2838533</accession><cross_references><pubmed>20053671</pubmed><doi>10.1093/hmg/ddp585 </doi></cross_references></HashMap>